Thursday, January 1, 2026 1/1/2026

Regulation of NMDAR-Mediated Synaptic Signaling

Award Number: R01NS125359
ORGANIZATION: NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 12/15/2021
PERIOD OF PERFORMANCE END DATE: 11/30/2026

Group Awards By:

View Award Description

Regulation of NMDAR-Mediated Synaptic Signaling - PROJECT SUMMARY/ABSTRACT We propose to study the NMDA-subtype (NMDARs) of ionotropic glutamate receptors (iGluRs) and their regulation by NRAP-1, the first identified NMDAR-specific auxiliary protein, which we recently discovered in a genetic screen for modifiers of NMDAR-mediated behavior in C. elegans. NMDARs are evolutionarily conserved and well known for their role in synaptic plasticity, i.e., long-term potentiation (LTP); their importance for cellular models of learning and memory; and their direct or indirect involvement in many neurological and psychiatric disorders. Although NRAP-1 modifies the function of postsynaptic NMDARs, we showed that it was released by presynaptic glutamatergic neurons. This discovery provided a major conceptual advance in our understanding of the regulation of NMDAR-mediated synaptic signaling, with implications for both the control of synaptic strength and for certain clinical disorders involving NMDARs. In preliminary experiments, we successfully obtained crystals of recombinantly produced NRAP-1 and determined the crystal structure at 1.9 Å resolution. Elucidating the structure of NRAP-1 has provided important new insight into how NRAP-1 modifies NMDAR function. By studying vertebrate and C. elegans NMDARs, we have also demonstrated a fundamental importance for the NMDAR amino-terminal domain (ATD) with respect to both receptor gating and to the mechanism of action of NRAP-1. We now plan to build on this foundational work and ask how NRAP-1 functions to modulate NMDAR function, i.e., what are the interactions between NRAP-1 and NMDARs, and how do these interactions change receptor kinetics? In contrast to overexpression of NMDARs, we discovered that overexpression of NRAP-1 in vivo significantly increased NMDAR-mediated currents and behavior. This has important implications for the control of synaptic plasticity. Furthermore, we found that NRAP-1 is actively transported along neural processes. Together, these findings suggest that modulating NRAP-1 secretion might be a mechanism used to regulate activity dependent changes in synaptic strength. Therefore, we will address the molecular requirements for the transport and secretion of NRAP-1. The relevance of our proposed studies is high because disorders of NMDAR-mediated signaling are implicated in synaptopathies associated with neurodegenerative disorders as well as for mental health illnesses such as schizophrenia and depression. Synaptic molecules are evolutionarily conserved, and our understanding of the mechanisms that regulate synaptic signaling has greatly benefited from genetics-based studies in invertebrates such as Drosophila and C. elegans. Notably, NMDARs and NRAP-1-like proteins appear to have co-evolved suggesting that vertebrate NMDARs are likely regulated by auxiliary proteins. We therefore anticipate that our planned studies will help provide a framework for a new mechanistic understanding of NMDARs centered on protein-protein interactions.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $475,617 )
2026	2026	UNIVERSITY OF UTAH	201 PRESIDENTS CIR	SALT LAKE CITY	UT	84112	SALT LAKE	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	000	5	12/23/2025	NON-COMPETING CONTINUATION	$475,617
														Subtotal = $475,617

Issue Date FY: 2025 ( Subtotal = $528,463 )
2025	2025	UNIVERSITY OF UTAH	201 PRESIDENTS CIR	SALT LAKE CITY	UT	84112	SALT LAKE	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	001	4	8/8/2025	NON-COMPETING CONTINUATION	$52,846
2025	2025	UNIVERSITY OF UTAH	201 PRESIDENTS CIR	SALT LAKE CITY	UT	84112	SALT LAKE	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	000	4	12/30/2024	NON-COMPETING CONTINUATION	$475,617
														Subtotal = $528,463

Issue Date FY: 2024 ( Subtotal = $512,609 )
2024	2024	UNIVERSITY OF UTAH	201 PRESIDENTS CIR	SALT LAKE CITY	UT	84112	SALT LAKE	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	000	3	11/20/2023	NON-COMPETING CONTINUATION	$475,617
2024	2024	UNIVERSITY OF UTAH	201 PRESIDENTS CIR	SALT LAKE CITY	UT	84112	SALT LAKE	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	001	3	4/30/2024	NON-COMPETING CONTINUATION	$36,992
														Subtotal = $512,609

Issue Date FY: 2023 ( Subtotal = $528,463 )
2023	2023	UNIVERSITY OF UTAH, THE	201 PRESIDENTS CIR	SALT LAKE CITY	UT	84112	SALT LAKE	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	000	2	12/9/2022	NON-COMPETING CONTINUATION	$475,617
2023	2023	UNIVERSITY OF UTAH, THE	201 PRESIDENTS CIR	SALT LAKE CITY	UT	84112	SALT LAKE	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	001	2	1/31/2023	NON-COMPETING CONTINUATION	$52,846
														Subtotal = $528,463

Issue Date FY: 2022 ( Subtotal = $528,463 )
2022	2022	UNIVERSITY OF UTAH, THE	201 PRESIDENTS CIR	SALT LAKE CITY	UT	84112	SALT LAKE	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	000	1	12/1/2021	NEW	$528,463
														Subtotal = $528,463

Grand Total All Awards = $2,573,615

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Regulation of NMDAR-Mediated Synaptic Signaling

Award Number: R01NS125359

ORGANIZATION: NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 12/15/2021

PERIOD OF PERFORMANCE END DATE: 11/30/2026

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer